Roche H - Search Results

1

Despas F, Roche H, Laurent G. Despas F, et al. Among authors: roche h. Bull Cancer. 2013 May;100(5):473-84. doi: 10.1684/bdc.2013.1738. Bull Cancer. 2013. PMID: 23694959 Review. French.

2

[Evolving strategies over time for treatment of breast cancer].

Roché H. Roché H. Bull Cancer. 2013 Sep;100(9):857-63. doi: 10.1684/bdc.2013.1805. Bull Cancer. 2013. PMID: 24004610 Review. French.

3

Prognostic factors of young women (≤ 35 years) with node positive breast cancer: possible influence on post-therapeutic follow-up.

Filleron T, Md FD, Kramar A, Spielmann M, Levy C, Fumoleau P, Canon JL, Martin AL, Roché H. Filleron T, et al. Among authors: roche h. Bull Cancer. 2013 Jul-Aug;100(7-8):22-9. doi: 10.1684/bdc.2013.1791. Bull Cancer. 2013. PMID: 23822935

4

[Future perspectives. From basic research to the development of new therapies aimed at the inhibition of the different stages of signal transduction: applications in breast cancer].

Campone M, Kerbrat P, Roché H, Bennouna J, Cuillière JC, Le Mevel B, Fumoleau P. Campone M, et al. Among authors: roche h. Bull Cancer. 2003 Oct;90(10):851-64. Bull Cancer. 2003. PMID: 14706914 Free article. Review. French.

5

Failure event types and prognostic factors after node-positive breast cancer in patients treated by adjuvant chemotherapy: impact on follow-up.

Filleron T, Kramar A, Dalenc F, Spielmann M, Fumoleau P, Kerbrat P, Martin AL, Roché H. Filleron T, et al. Among authors: roche h. Bull Cancer. 2012 Jun;99(6):E64-74. doi: 10.1684/bdc.2012.1592. Bull Cancer. 2012. PMID: 22641367

6

Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.

Zindy P, Bergé Y, Allal B, Filleron T, Pierredon S, Cammas A, Beck S, Mhamdi L, Fan L, Favre G, Delord JP, Roché H, Dalenc F, Lacroix-Triki M, Vagner S. Zindy P, et al. Among authors: roche h. Cancer Res. 2011 Jun 15;71(12):4068-73. doi: 10.1158/0008-5472.CAN-11-0420. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498638

7

[Dose density and dose intensity in the treatment of breast cancer].

Saintigny P, Assouad S, Gligorov J, Selle F, Roché H, Breau JL, Morère JF, Lotz JP. Saintigny P, et al. Among authors: roche h. Bull Cancer. 2004 Dec 1;91 Suppl 4:S244-53. Bull Cancer. 2004. PMID: 15899616 Free article. Review. French.

8

[Academic carriers in oncology and radiotherapy: Explanations for the readers of Bulletin du Cancer].

Soria JC, Bastian G, Bolotine L, Calais G, Céraline J, de Cremoux P, Espié M, Karayan-Tapon L, Laprie A, Mazeron JJ, Négrier S, Roché H. Soria JC, et al. Among authors: roche h. Bull Cancer. 2016 Sep;103(9):719-29. doi: 10.1016/j.bulcan.2016.07.004. Epub 2016 Aug 23. Bull Cancer. 2016. PMID: 27561824 French. No abstract available.

9

[Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].

Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D. Martel P, et al. Among authors: roche h. Bull Cancer. 2008 Jul-Aug;95(7):763-72. doi: 10.1684/bdc.2008.0640. Bull Cancer. 2008. PMID: 18755653 French.

10

Epirubicin-based chemotherapy as adjuvant treatment for poor prognosis, node-negative breast cancer: 10-year follow-up results of the French Adjuvant Study Group 03 trial.

Héry M, Bonneterre J, Roché H, Luporsi E, Kerbrat P, Namer M, Fumoleau P, Monnier A, Fargeot P. Héry M, et al. Among authors: roche h. Bull Cancer. 2006 Oct;93(10):E109-14. Bull Cancer. 2006. PMID: 17074656 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

597 results

Search Page

Filters